Viewing Study NCT06952660


Ignite Creation Date: 2025-12-25 @ 2:11 AM
Ignite Modification Date: 2025-12-27 @ 11:38 PM
Study NCT ID: NCT06952660
Status: RECRUITING
Last Update Posted: 2025-12-12
First Post: 2025-04-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Sponsor: Pfizer
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: C5721005
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View